Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF. Trum M, Riechel J, Schollmeier E, Lebek S, et al. Cardiovasc Res 2024;120:999-1010.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Trum M, Riechel J, Schollmeier E, Lebek S, et al. Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF. Cardiovasc Res 2024;120:999-1010.
PMID: 38728438